Skip to main content

Point72 Asset Management, L.P.

Position in ESPR — Esperion Therapeutics, Inc.

CIK 1603466 STAMFORD, CT

Position in ESPR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
1,689,372
+76654.7% QoQ
Ownership
0.656%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
12 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ESPR Over Time

Shares Held

Position Value (USD)

Derivatives in ESPR

reported options exposure · as of Jun 30, 2024
CallValue
$0
CallShares
0
PutValue
$0
PutShares
260,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $450,936,643 across 22 Drug Manufacturers - Specialty & Generic names.

# Ticker Company Shares Value (USD) Open

All Filings in ESPR

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 1,689,372
2025-09-30 2,201
2024-06-30 67,070
2024-06-30 260,000
2024-03-31 16,070
2024-03-31 200,000
2023-12-31 4,800
2023-09-30 3,097,852
2023-06-30 4,975,000
2023-03-31 3,600,000
2022-12-31 2,277,000
2022-12-31 150,000
2022-09-30 50,000
2022-09-30 2,788,300
2022-06-30 1,063,096
2021-03-31 648,200